Your account is not claimed yet. You can sign up with ORCID to claim your account.

Dag Erlend Olberg

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 6

Top Venues

Journal of labelled compounds & radiopharmaceuticals

Molecules (Basel, Switzerland)

EJNMMI radiopharmacy and chemistry

Molecular cancer therapeutics

Universitet i Oslo

Universitetet i Tromsø Institutt for farmasi (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitet i Oslo Jan 5o 2015

Norway

Associated Professor :: Department of Pharmaceutical Chemistry

Education History

Universitetet i Tromsø Institutt for farmasi Oct 1o 2005 - Nov 20o 2009

Norway

PHD :: GE Healthcare Oslo/UIT - Tromsø

Publications

Vegard Torp Lien, Emily Hauge, Syed Nuruddin, Jo Klaveness, Dag Erlend Olberg
Synthesis and preclinical evaluation of a selective MET kinase positron emission tomography tracer. Journal of labelled compounds & radiopharmaceuticals (2023)
Raphaël Hoareau, Tore Bach-Gansmo, Paul Cumming, Dag Erlend Olberg
A new automated and putatively versatile synthesis of the PSMA-ligand derivative [ 18 F]DCFPyL using the FASTlab TM synthesizer. EJNMMI radiopharmacy and chemistry 7 (1) (2022)
Synnøve Nymark Aasen, Heidi Espedal, Christopher Florian Holte, Olivier Keunen, Tine Veronika Karlsen, Olav Tenstad, Zaynah Maherally, Hrvoje Miletic, Tuyen Hoang, Anne Vaag Eikeland, Habib Baghirov, Dag Erlend Olberg, Geoffrey John Pilkington, Gobinda Sarkar, Robert B Jenkins, Terje Sundstrøm, Rolf Bjerkvig, Frits Thorsen
Improved Drug Delivery to Brain Metastases by Peptide-Mediated Permeabilization of the Blood-Brain Barrier. Molecular cancer therapeutics 18 (11) (2019)
Paul Cumming, János Marton, Tuomas Olavi Lilius, Dag Erlend Olberg, Axel Rominger
A Survey of Molecular Imaging of Opioid Receptors. Molecules (Basel, Switzerland) 24 (22) (2019)
Feng-Ling Tukun, Dag Erlend Olberg, Patrick J Riss, Ira Haraldsen, Anita Kaass, Jo Klaveness
Recent Development of Non-Peptide GnRH Antagonists. Molecules (Basel, Switzerland) 22 (12) (2017)
Vegard Torp Lien, Jo Klaveness, Dag Erlend Olberg
One-step synthesis of [18 F]cabozantinib for use in positron emission tomography imaging of c-Met. Journal of labelled compounds & radiopharmaceuticals 61 (1) (2017)

Dag Erlend Olberg.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Dag Erlend Olberg